|Description||Drug Discovery Company|
|Series A, 11/09 |
ARCH Venture Partners
|Venture Round, 3/12 ||$10.8M|
Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.